Alan F. Denenberg

Davis Polk advised the sole bookrunner in connection with the SEC-registered offering of 2,329,000 shares of Class A common stock of Appian Corporation by Appian and certain existing…

Davis Polk advised the joint book-running managers in connection with an offering by Juniper Networks, Inc. of $500 million aggregate principal amount of its 3.750% notes due 2029. Davis…

Davis Polk is advising Pivotal Software, Inc. in connection with its sale to VMware, Inc. for a total enterprise value of approximately $2.7 billion. Closing of the transaction is subject…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Proofpoint, Inc. of $920 million aggregate principal amount of its 0.25% convertible senior notes due…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Insight Enterprises, Inc. of $300 million aggregate principal amount of its 0.750% convertible senior…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the follow-on offering of 5,227,272 shares of common stock of Allakos Inc. for…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering of common stock by Seattle Genetics, Inc. for gross…

Davis Polk advised AssetMark Financial Holdings, Inc. on its SEC-registered initial public offering of 14,375,000 shares of common stock for an aggregate price to the public of…

Davis Polk advised Calm.com, Inc. in connection with its investment in convertible notes and common stock warrants of XpresSpa Group, Inc. Concurrent with the investment, Calm amended its…

Davis Polk advised McKesson Corporation on Change Healthcare Inc.’s SEC-registered initial public offering of 49,285,713 shares of its common stock at a price to the public of $13 per…